A rare-disease biotech company needed support developing a prioritized digital investment and clinical trial acceleration strategy in an increasingly competitive trial landscape.
Acquis conducted an external landscape assessment of capabilities and investments across the pharma and biotech landscape, including patient engagement, clinical development, and clinical operations. Additionally, we developed a methodology and prioritization framework to catalog challenges, recognize gaps, quantify, and prioritize future-state opportunities.
Patient-focused clinical acceleration and engagement recommendations through novel digital approaches with a multi-year roadmap and PoC lead investment plan.
299 Broadway
Suite 1200
New York, NY 10097
© 2025 Acquis Consulting Group L.L.C
299 Broadway
Suite 1200
New York, NY 10097